Wird geladen...

Randomized Study Combining Interferon & Glatiramer Acetate in Multiple Sclerosis

OBJECTIVE: A double-blind, randomized, controlled study to determine if combined use of interferon beta-1a (IFN) 30ug IM weekly and glatiramer acetate (GA) 20mg daily is more efficacious than either agent alone in relapsing-remitting multiple sclerosis (RRMS). METHODS: 1008 participants were randomi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lublin, Fred D., Cofield, Stacey S., Cutter, Gary R., Conwit, Robin, Narayana, Ponnada A., Nelson, Flavia, Salter, Amber R., Gustafson, Tarah, Wolinsky, Jerry S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3631288/
https://ncbi.nlm.nih.gov/pubmed/23424159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.23863
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!